- Home
- CELZ vs XBIO Comparison
CELZ vs XBIO Comparison
Compare CELZ & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- XBIO
- Stock Information
- Founded
- CELZ 1998
- XBIO N/A
- Country
- CELZ United States
- XBIO United States
- Employees
- CELZ N/A
- XBIO N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- XBIO Health Care
- Exchange
- CELZ Nasdaq
- XBIO Nasdaq
- Market Cap
- CELZ 5.5M
- XBIO 5.8M
- IPO Year
- CELZ N/A
- XBIO N/A
- Fundamental
- Price
- CELZ $1.93
- XBIO $2.72
- Analyst Decision
- CELZ
- XBIO Hold
- Analyst Count
- CELZ 0
- XBIO 1
- Target Price
- CELZ N/A
- XBIO N/A
- AVG Volume (30 Days)
- CELZ 100.5K
- XBIO 9.9K
- Earning Date
- CELZ 05-09-2025
- XBIO 05-08-2025
- Dividend Yield
- CELZ N/A
- XBIO N/A
- EPS Growth
- CELZ N/A
- XBIO N/A
- EPS
- CELZ N/A
- XBIO N/A
- Revenue
- CELZ $11,000.00
- XBIO $2,500,284.00
- Revenue This Year
- CELZ N/A
- XBIO $14.23
- Revenue Next Year
- CELZ N/A
- XBIO N/A
- P/E Ratio
- CELZ N/A
- XBIO N/A
- Revenue Growth
- CELZ 22.22
- XBIO N/A
- 52 Week Low
- CELZ $1.69
- XBIO $2.20
- 52 Week High
- CELZ $6.90
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- CELZ 38.56
- XBIO 48.09
- Support Level
- CELZ $1.90
- XBIO $2.32
- Resistance Level
- CELZ $2.10
- XBIO $2.61
- Average True Range (ATR)
- CELZ 0.24
- XBIO 0.15
- MACD
- CELZ 0.06
- XBIO 0.07
- Stochastic Oscillator
- CELZ 36.49
- XBIO 99.83
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.